Literature DB >> 17268021

Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.

Jong-Lyel Roh1, Chang Hwan Ryu, Seung-Ho Choi, Jae Seung Kim, Jeong Hyun Lee, Kyung-Ja Cho, Soon Yuhl Nam, Sang Yoon Kim.   

Abstract

UNLABELLED: The clinical utility of 18F-FDG PET in evaluating salivary gland malignancies has not been well defined. We therefore evaluated the utility of 18F-FDG PET in management for patients with salivary gland cancers.
METHODS: Thirty-four patients with newly diagnosed salivary gland cancers underwent CT and 18F-FDG PET before surgical resection with radiotherapy. The diagnostic accuracies of CT and 18F-FDG PET for detecting primary tumors and neck metastases were compared with a histopathologic reference. We determined the relationship between the maximum standardized uptake value (SUV) of the tumor and clinicopathologic parameters such as sex, age, local tumor invasion, T and N categories, TNM stage, and histologic grade, as well as their associations with disease-free survival (DFS).
RESULTS: 18F-FDG PET was more sensitive than CT for the detection of primary tumors (91.2% vs. 79.4%; P < 0.05), cervical metastases (80.5% vs. 56.1%; P < 0.05), and distant metastases in 2 patients at initial staging. High-grade malignancies had higher mean maximum SUVs than did low- and intermediate-grade malignancies (4.6 vs. 2.8; P = 0.011). T and N categories were independent determinants of DFS (P < 0.05), but the maximum SUV (4.0) was not. During a mean follow-up of 25.1 mo, 18F-FDG PET correctly diagnosed local-regional recurrences in 6 patients and new distant metastases in 9 patients.
CONCLUSION: Our findings indicate that, in patients with salivary gland malignancies, 18F-FDG PET is clinically useful in initial staging, histologic grading, and monitoring after treatment but not in predicting patient survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17268021

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

1.  Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?

Authors:  Ayse Tuba Karagulle Kendi; Kelly R Magliocca; Amanda Corey; James R Galt; Jeffrey Switchenko; J Trad Wadsworth; Mark W El-Deiry; David M Schuster; Nabil F Saba; Patricia A Hudgins
Journal:  AJR Am J Roentgenol       Date:  2016-06-08       Impact factor: 3.959

2.  Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis.

Authors:  Giorgio Treglia; Francesco Bertagna; Ramin Sadeghi; Barbara Muoio; Luca Giovanella
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-28       Impact factor: 2.503

3.  Utility of metabolic heterogeneity factor in differentiating malignant versus benign parotid uptake on 18F FDG PET-CT.

Authors:  Ramin Alipour; Steven Smith; Sandeep K Gupta
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20

Review 4.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

5.  Adenoid Cystic Carcinoma of the Oral Cavity: Radiology-Pathology Correlation.

Authors:  Imran Uraizee; Nicole A Cipriani; Daniel T Ginat
Journal:  Head Neck Pathol       Date:  2017-09-06

Review 6.  Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imaging.

Authors:  Angelo Castello; Laura Olivari; Egesta Lopci
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-02-05

Review 7.  Salivary gland carcinomas.

Authors:  Tobias Ettl; Stephan Schwarz-Furlan; Martin Gosau; Torsten E Reichert
Journal:  Oral Maxillofac Surg       Date:  2012-07-29

8.  Variety and complexity of fluorine-18-labelled fluoro-2-deoxy-D-glucose accumulations in the oral cavity of patients with oral cancers.

Authors:  S Kito; H Koga; M Kodama; M Habu; S Kokuryo; N Yamamoto; M Oda; T Nishino; M Zhang; K Matsuo; N Wakasugi-Sato; S Matsumoto-Takeda; Y Seta; D Yoshiga; T Kaneuji; S Nogami; I Yoshioka; Y Yamashita; T Tanaka; I Miyamoto; C Kitamura; K Tominaga; Y Morimoto
Journal:  Dentomaxillofac Radiol       Date:  2013-04-22       Impact factor: 2.419

9.  Use of 18F-fluorodeoxyglucose positron emission tomography in patients with rare head and neck cancers.

Authors:  Jong-Lyel Roh; Byoung Jae Moon; Jae Seung Kim; Jeong Hyun Lee; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Bong-Jae Lee; Sang Yoon Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-06-20       Impact factor: 3.372

10.  The clinical usefulness of (18)F-FDG PET/CT for the evaluation of lymph node metastasis in periorbital malignancies.

Authors:  Chung Hwan Baek; Man Ki Chung; Han Sin Jeong; Young Ik Son; Jeesun Choi; Yoon Duck Kim; Joon Young Choi; Hyung Jin Kim; Young Hyeh Ko
Journal:  Korean J Radiol       Date:  2009 Jan-Feb       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.